header logo image


Page 463«..1020..462463464465..470480..»

Yoga asanas and breathing exercises to boost immunity during monsoon, keep infections at bay – Times Now

July 11th, 2020 10:45 pm

Yoga asanas and breathing exercises to boost immunity during monsoon, keep infections at bay  |  Photo Credit: iStock Images

New Delhi: The monsoon season invariably brings with it water-borne infections, respiratory illnesses, allergies, and stomach disorders. But nature has provided us with an immune system, a highly advanced piece of technology in-built in the human body. The immune system protects us against harmful substances from the environment, diseases and harmful cells. There are two types of immune systems the active and the passive immune system. The main parts of the immune system are white blood cells, antibodies, the complement system, the lymphatic system, the spleen, the thymus, and the bone marrow.

By keeping both the mind and body strong, you can raise your immunity levels. This has to be combined with a proper diet that includes immunity building foods. The following yoga practices will help you to improve your immune system and develop your defences. Yoga stimulates the lymphatic system removing toxins from the body, conditions the lungs and respiratory tract, and ensures the optimal functioning of your organs. Research shows that even 20 minutes of yoga on a regular basis can boost your overall health.

Formation of the posture

Begin with Dandasana Ensure that your knees are slightly bent while your legs are stretched out forward Extend your arms upward and keep your spine erect Exhale and empty your stomach of air With the exhale, bend forward at the hip and place your upper body on your lower body Lower your arms and grip your big toes with your fingers Try to touch your knees with your nose

Breathing Methodology - Exhale while bending forward

In Sanskrit, Kapal means skull and Bhati means shining/illuminating. Therefore, this Kapalbhati Pranayam is also known as Skull Shining Breathing Technique.

Method

Add these asanas and flow to your regular exercise routine to protect your health during the monsoons. Equip yourself with the necessary protective gear like jackets, raincoats and rain boots to keep yourself dry. Choose only trusted sources when it comes to eating outside to prevent falling prey to any infections. With a little care, the monsoon can easily become the best season of the year.

Grand Master Akshar is a guest contributor. Views expressed are personal.

Read the original:
Yoga asanas and breathing exercises to boost immunity during monsoon, keep infections at bay - Times Now

Read More...

Cancer trial to focus on protecting patients from COVID-19 infection – 100 Mile House Free Press

July 11th, 2020 10:45 pm

A national clinical trial this summer will focus on protecting cancer patients against severe COVID-19 infection by attempting to boost their compromised immune system.

Researchers from The Ottawa Hospital say they want to explore the potential of IMM-101, a preparation featuring a dead pathogen containing properties that can stimulate the first-response arm of the immune system.

Study lead Dr. Rebecca Auer, surgical oncologist and director of cancer research at the Ottawa Hospital, says it could help experts understand why some COVID-19 patients are relatively asymptomatic while others end up in intensive care or die.

The difference it seems between these two different presentations has to do with how strong your innate, or your sort of non-specific, first-line defence immune system response is to the virus, Auer said Wednesday.

And so were hoping that by boosting and stimulating this innate immune response, particularly in those vulnerable patients that have a reduced immune response to begin with, wed be able to prevent symptomatic infections and prevent serious infections.

Cancer patients are at much higher risk of severe complications from COVID-19 because chemotherapy, cancer surgery and radiation treatments suppress innate immunity even further.

Auer points to an urgent need to protect them while the world waits for an effective COVID-19 vaccine, which could take another year or more to develop, test, and implement.

A successful trial could also protect cancer patients against other respiratory infections as well as the coming flu season, says Auer, noting the threat of illness is a fairly big problem for those undergoing treatment.

A study demonstrated that about 13 to 15 per cent of cancer patients will have to delay or stop their treatment because of influenza during the average flu season, she says.

And also cancer patients dont respond as well to the influenza vaccine every year because their immune system isnt as strong. So we think that the IMM-101 may in itself be able to help prevent symptomatic influenza infections.

Auer says IMM-101 has also been tested elsewhere for its anti-cancer properties and that, too, will be examined in this trial, although its not the primary objective.

The researchers say the bacteria, Mycobacterium obuense, is safe to use in cancer patients because it has been killed by heat.

The Canadian study will recruit 1,500 patients currently receiving cancer treatment, and participants will be randomly assigned to receive either regular care, or regular care plus IMM-101.

Auer says the treatment would be administered as an injection in the arm, to be followed by two more booster shots.

Researchers will follow patients for a year, watching for any respiratory infections and monitoring whether the treatment works and how long it lasts.

The trials will take place in eight centres located in Ontario, British Columbia and Quebec.

Researchers say people interested in participating should speak with their cancer specialist.

Researchers from the Ottawa Hospital came up with the idea and worked with the Canadian Cancer Trials Group at Queens University to design the trial.

Dr. Chris OCallaghan of the Queens University group notes cancer patients are also at greater risk of COVID-19 infection because they require regular medical care, making it difficult to adhere fully to public health guidelines.

These patients are unable to practice social isolation due to the need to regularly attend hospital to receive critically important cancer treatment, says OCallaghan, who will oversee the trial.

Auer says a successful trial of IMM-101 could also suggest usefulness in treating any patient with a reduced innate immune system, such as older patients with chronic illness.

She notes that the tuberculosis vaccine known as BCG which uses a similar formulation to IMM-101 but uses live bacteria instead of dead bacteria is being tested around the world to see if it can boost the immunity of health-care workers exposed to COVID-19.

Funding and in-kind support, valued at $2.8 million, comes from the Canadian Cancer Society, BioCanRx, the Ontario Institute for Cancer Research, The Ottawa Hospital Foundation, The Ottawa Hospital Academic Medical Organization, ATGen Canada/NKMax, and Immodulon Therapeutics, the manufacturer of IMM-101.

The Canadian Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Coronavirus

Here is the original post:
Cancer trial to focus on protecting patients from COVID-19 infection - 100 Mile House Free Press

Read More...

Cell Separation Technology Market is Anticipated to Expand at a CAGR of ~ 12% during 2019 2027 – Press Release – Digital Journal

July 11th, 2020 9:50 pm

Cell Separation Technology Market is boosted by advancements in technology, increase in the geriatric population, surge in investments in research & development.

Transparency Market Research (TMR) has published a new report on the global cell separation technology market for the forecast period of 20192027. According to the report, the global cell separation technology market was valued at ~ US$ 5 Bn in 2018, and is projected to expand at a double-digit CAGR during the forecast period.

Overview

Cell separation, also known as cell sorting or cell isolation, is the process of removing cells from biological samples such as tissue or whole blood. Cell separation is a powerful technology that assists biological research. Rising incidences of chronic illnesses across the globe are likely to boost the development of regenerative medicines or tissue engineering, which further boosts the adoption of cell separation technologies by researchers.

Expansion of the global cell separation technology market is attributed to an increase in technological advancements and surge in investments in research & development, such as stem cell research and cancer research. The rising geriatric population is another factor boosting the need for cell separation technologies Moreover, the geriatric population, globally, is more prone to long-term neurological and other chronic illnesses, which, in turn, is driving research to develop treatment for chronic illnesses. Furthermore, increase in the awareness about innovative technologies, such as microfluidics, fluorescent-activated cells sorting, and magnetic activated cells sorting is expected to propel the global cell separation technology market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1925

North America dominated the global cell separation technology market in 2018, and the trend is anticipated to continue during the forecast period. This is attributed to technological advancements in offering cell separation solutions, presence of key players, and increased initiatives by governments for advancing the cell separation process. However, insufficient funding for the development of cell separation technologies is likely to hamper the global cell separation technology market during the forecast period. Asia Pacific is expected to be a highly lucrative market for cell separation technology during the forecast period, owing to improving healthcare infrastructure along with rising investments in research & development in the region.

Rising Incidences of Chronic Diseases, Worldwide, Boosting the Demand for Cell Therapy

Incidences of chronic diseases such as diabetes, obesity, arthritis, cardiac diseases, and cancer are increasing due to sedentary lifestyles, aging population, and increased alcohol consumption and cigarette smoking. According to the World Health Organization (WHO), by 2020, the mortality rate from chronic diseases is expected to reach 73%, and in developing counties, 70% deaths are estimated to be caused by chronic diseases. Southeast Asia, Eastern Mediterranean, and Africa are expected to be greatly affected by chronic diseases. Thus, the increasing burden of chronic diseases around the world is fuelling the demand for cellular therapies to treat chronic diseases. This, in turn, is driving focus and investments on research to develop effective treatments. Thus, increase in cellular research activities is boosting the global cell separation technology market.

Increase in Geriatric Population Boosting the Demand for Surgeries

The geriatric population is likely to suffer from chronic diseases such as cancer and neurological disorders more than the younger population. Moreover, the geriatric population is increasing at a rapid pace as compared to that of the younger population. Increase in the geriatric population aged above 65 years is projected to drive the incidences of Alzheimers, dementia, cancer, and immune diseases, which, in turn, is anticipated to boost the need for corrective treatment of these disorders. This is estimated to further drive the demand for clinical trials and research that require cell separation products. These factors are likely to boost the global cell separation technology market.

According to the United Nations, the geriatric population aged above 60 is expected to double by 2050 and triple by 2100, an increase from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion by 2100.

Request for Analysis of COVID19 Impact on Cell Separation Technology Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1925

Productive Partnerships in Microfluidics Likely to Boost the Cell Separation Technology Market

Technological advancements are prompting companies to innovate in microfluidics cell separation technology. Strategic partnerships and collaborations is an ongoing trend, which is boosting the innovation and development of microfluidics-based products. Governments and stakeholders look upon the potential in single cell separation technology and its analysis, which drives them to invest in the development of microfluidics. Companies are striving to build a platform by utilizing their expertise and experience to further offer enhanced solutions to end users.

Stem Cell Research to Account for a Prominent Share

Stem cell is a prominent cell therapy utilized in the development of regenerative medicine, which is employed in the replacement of tissues or organs, rather than treating them. Thus, stem cell accounted for a prominent share of the global market. The geriatric population is likely to increase at a rapid pace as compared to the adult population, by 2030, which is likely to attract the use of stem cell therapy for treatment. Stem cells require considerably higher number of clinical trials, which is likely to drive the demand for cell separation technology, globally. Rising stem cell research is likely to attract government and private funding, which, in turn, is estimated to offer significant opportunity for stem cell therapies.

Biotechnology & Pharmaceuticals Companies to Dominate the Market

The number of biotechnology companies operating across the globe is rising, especially in developing countries. Pharmaceutical companies are likely to use cells separation techniques to develop drugs and continue contributing through innovation. Growing research in stem cell has prompted companies to own large separate units to boost the same. Thus, advancements in developing drugs and treatments, such as CAR-T through cell separation technologies, are likely to drive the segment.

As per research, 449 public biotech companies operate in the U.S., which is expected to boost the biotechnology & pharmaceutical companies segment. In developing countries such as China, China Food and Drug Administration (CFDA) reforms pave the way for innovation to further boost biotechnology & pharmaceutical companies in the country.

Buy Cell Separation Technology Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1925&ltype=S

Global Cell Separation Technology Market: Prominent Regions

North America to Dominate Global Market, While Asia Pacific to Offer Significant Opportunity

In terms of region, the global cell separation technology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global market in 2018, followed by Europe. North America accounted for a major share of the global cell separation technology market in 2018, owing to the development of cell separation advanced technologies, well-defined regulatory framework, and initiatives by governments in the region to further encourage the research industry. The U.S. is a major investor in stem cell research, which accelerates the development of regenerative medicines for the treatment of various long-term illnesses.

The cell separation technology market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in healthcare expenditure and large patient population, especially in countries such as India and China. Rising medical tourism in the region and technological advancements are likely to drive the cell separation technology market in the region.

Launching Innovative Products, and Acquisitions & Collaborations by Key Players Driving Global Cell Separation Technology Market

The global cell separation technology market is highly competitive in terms of number of players. Key players operating in the global cell separation technology market include Akadeum Life Sciences, STEMCELL Technologies, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotech, 10X Genomics, Thermo Fisher Scientific, Inc., Zeiss, GE Healthcare Life Sciences, PerkinElmer, Inc., and QIAGEN.

These players have adopted various strategies such as expanding their product portfolios by launching new cell separation kits and devices, and participation in acquisitions, establishing strong distribution networks. Companies are expanding their geographic presence in order sustain in the global cell separation technology market. For instance, in May 2019, Akadeum Life Sciences launched seven new microbubble-based products at a conference. In July 2017, BD received the U.S. FDAs clearance for its BD FACS Lyric flow cytometer system, which is used in the diagnosis of immunological disorders.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media ContactCompany Name: Transparency Market ResearchContact Person: Mr. Rohit BhiseyEmail: Send EmailPhone: 5186181030Address:90 Sate Street, Suite 700 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.transparencymarketresearch.com/

More:
Cell Separation Technology Market is Anticipated to Expand at a CAGR of ~ 12% during 2019 2027 - Press Release - Digital Journal

Read More...

Absorbable and Non-Absorbable Sutures Market Expansion Projected to Gain an Uptick During 2019-2026 – Jewish Life News

July 11th, 2020 9:48 pm

The Global Absorbable and Non-Absorbable Sutures market gives detailed Evaluation about all the Important aspects related to the marketplace. The analysis on global Absorbable and Non-Absorbable Sutures economy, offers profound insights regarding the Absorbable and Non-Absorbable Sutures market covering all of the crucial aspects of the market. Moreover, the report offers historical information with future prediction over the forecast period. Various important factors such as market trends, earnings growth patterns market shares and demand and supply are contained in almost all the market research report for every industry. A number of the vital facets analysed in the report contains market share, production, key regions, earnings rate in addition to key players.

The study of various segments of the global market are also Covered in the study report. In addition to that, for the prediction periods determination of variables such as market size and the competitive landscape of this sector is analysed in the report. On account of the rising globalization and digitization, there are new tendencies coming to the marketplace daily. The study report provides the in-depth analysis of all these tendencies.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2713562&source=atm

In addition, the Absorbable and Non-Absorbable Sutures market report also provides the Latest trends in the Global Absorbable and Non-Absorbable Sutures marketplace with the help of primary as well as secondary research methods. Additionally, the research report on Absorbable and Non-Absorbable Sutures market provides a wide analysis of the market including market overview, production, producers, dimensions, price, value, growth rate, earnings, prices, export, consumption, and sales revenue of this Global Absorbable and Non-Absorbable Sutures market. On the flip side, the Absorbable and Non-Absorbable Sutures market report also studies the industry status for the prediction period. However, this can help to grow the advertising opportunities throughout the world in addition to major market suppliers.

Segment by Type, the Absorbable and Non-Absorbable Sutures market is segmented intoAbsorbable SuturesNon-Absorbable Sutures

Segment by Application, the Absorbable and Non-Absorbable Sutures market is segmented intoCardiovascularOrthopedicGynecologyOpthalmologyGeneral SurgeryOthers

Regional and Country-level AnalysisThe Absorbable and Non-Absorbable Sutures market is analysed and market size information is provided by regions (countries).The key regions covered in the Absorbable and Non-Absorbable Sutures market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.Competitive Landscape and Absorbable and Non-Absorbable Sutures Market Share Analysis

Absorbable and Non-Absorbable Sutures market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Absorbable and Non-Absorbable Sutures by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Absorbable and Non-Absorbable Sutures business, the date to enter into the Absorbable and Non-Absorbable Sutures market, Absorbable and Non-Absorbable Sutures product introduction, recent developments, etc.The major vendors covered:B. Braun Melsungen AGEthiconSmith & NephewDemetech CorporationConmed CorporationW.L. Gore & AssociatesTephaMeta BiomedZimmer BiometCP MedicalMiltex (A Integra LifeSciences Corporation Company)Assut Medical SarlDyNek PtyFootbergStoeltingUnimed Medical IndustriesTeleflex IncorporatedBoston Scientific CorporationMedtronicSurgical Specialties CorporationResorba Medical GmbHMedline IndustriesAD SurgicalSantec MedicalprodukteClinisutCoreflonAspen SurgicalMedipacSuturesPierson Surgical

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2713562&source=atm

The Absorbable and Non-Absorbable Sutures market report provides useful insights for Every established and advanced players across the world. Furthermore the Absorbable and Non-Absorbable Sutures market report provides accurate analysis for the shifting competitive dynamics. This study report comprises a complete analysis of future expansion concerning the evaluation of the mentioned prediction interval. The Absorbable and Non-Absorbable Sutures market report provides a thorough study of the technological growth outlook over time to be aware of the market growth rates. The Absorbable and Non-Absorbable Sutures marketplace report also has innovative analysis of the huge number of unique factors that are boosting or functioning as well as regulating the Absorbable and Non-Absorbable Sutures marketplace growth.

A systematized methodology can be utilized to make a Report on the Global Absorbable and Non-Absorbable Sutures market. For the research of market on the terms of research Approaches, these techniques are useful. All of the Information Regarding the Products, manufacturers, vendors, clients and much more is covered in research reports. Various important factors like market trends, revenue Growth patterns market stocks and supply and demand are included in virtually all The market study report for every business. Adaptation of fresh ideas and Accepting the latest tendencies are a few the reasons for any markets growth. The Global Absorbable and Non-Absorbable Sutures market research report gives the deep understanding concerning the Regions where the market is impactful.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2713562&licType=S&source=atm

More:
Absorbable and Non-Absorbable Sutures Market Expansion Projected to Gain an Uptick During 2019-2026 - Jewish Life News

Read More...

Frightening projection of COVID-19’s effect on HIV treatment – Jamaica Observer

July 11th, 2020 9:47 pm

'); } else { $(".fotorama-caption").addClass("remove_caption"); } }) .fotorama();

In March this year we reported Dr Jennifer Brown Tomlinson, medical director at Jamaica AIDS Support for Life (JASL), urging people living with HIV to ensure that they take their medication daily.

A compromised immune system, Dr Tomlinson cautioned, may not be able to function at its optimum to fight against the coronavirus.

Said Dr Tomlinson: People living with HIV who are on their antiretroviral medication have the same risk [of contracting the novel coronavirus] as the normal population. All of the precautions that are being advised for the general population also apply to people living with HIV who are adherent to their antiretovirals.

That very sound advice takes on more relevance now as we are being told by health experts that COVID-19 could cause an additional half a million AIDS deaths if treatment is disrupted long term.

That chilling projection was made Monday at the start of the virtual International AIDS Conference at which it was noted that the COVID-19 pandemic was jeopardising years of progress against HIV.

The United Nations (UN), in its annual report, pointed out that the world was already way off course in its plan to end the HIV/AIDS threat before the COVID-19 outbreak.

According to the UN, despite the fact that AIDS-related deaths have fallen by 60 per cent since the peak of the HIV epidemic in 2004, approximately 690,000 people still died from the virus and 1.7 million people were infected last year.

There are now almost 40 million people living with HIV worldwide.

The emergence and spread of the novel coronavirus now means that the UN's target of reducing AIDS-related deaths and new HIV infections to fewer than 500,000 this year will now be missed.

A key contributor to that danger is that the pandemic is impacting access to preventative medicine among communities at risk because of lockdowns and distribution difficulties.

A report from the UN conference tells us that one model run in conjunction with the World Health Organization (WHO) showed that if COVID-19 measures disrupted HIV treatment programmes for six months it could leave an additional 500,000 people dead.

Indeed, WHO Director General Dr Tedros Adhanom Ghebreyesus is reported as saying: We cannot let the COVID-19 pandemic undo the hard-won gains in the global response to this disease.

The information coming out of the UN conferences should not be lost on the just over 32,000 people living with HIV in Jamaica. Those who are not compliant with their medication need to heed Dr Tomlinson's advice. In fact, anyone living with HIV should not, in the first place, be in a position of non-compliance.

As it now stands, our health authorities, and indeed the Government, need to ensure that the COVID-19 pandemic does not result in a shortage of antiretroviral medicines here.

For, while, as we have already stated, we are disappointed that Jamaica will not meet the Joint United Nations Programme on HIV/AIDS 90-90-90 target, which was set to be attained this year, we are encouraged that JASL has already achieved one of the targets and is close to the 2020 goal of having 90 per cent of its more than 730 HIV-positive clients virally suppressed.

Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at http://bit.ly/epaperlive

See the rest here:
Frightening projection of COVID-19's effect on HIV treatment - Jamaica Observer

Read More...

How the NBA bubble has taken shape in Disney World – USA TODAY

July 11th, 2020 9:47 pm

From therelative isolation at the Walt Disney World Resortto dozens of pages of policies and procedures, the NBA is constructinga social bubble in the Orlando area to protect its teams and the 2019-20 seasonfrom COVID-19.

Overall, health experts have praised the NBAs return-to-play guidelines. Yet they also expressed concerns, including testing frequency, uniformity of testing kits and length of isolation periods.

I havent seen anything thats this comprehensive from anyone," Dr. Rishi Desai, the chief medical officer at Osmosis and an infection disease physician, told USA TODAY Sports in June."Not just the federal government I havent seen state governments put anything out this comprehensive and havent seen any industr thats put out something this comprehensive."

Few places could offer the 22 teams and NBA staff as many playing facilities, rooms and amenities with minimal exposureto the public. The NBA's multiyear TV contract with ESPN owned by Disney probably didn't hurt either.

The resort's 220-acre ESPN Wide World of Sports Complex has more than a dozen practice courts and enough game-quality courts to play and broadcast three games at once,though that's not currently planned.

The 22 teams will each play eight seeding games starting July 30 to determine the final standings and who makes the playoffs. You can search, sort or scroll through all 88 seeding games below.

Scheduling has been one strategy theNBA has employed to reduce the number of potentialcontacts.

Family and guests won't be welcomed to the resort until the seeding games and first round of the playoffs are completed.

That keeps potentially infected guestsoutside the NBA's bubble for more than seven weeks. During that time,more than half of the invited teams will be eliminated in the seeding round or playoffs.

The NBA has made a similar calculation with the teams' accommodations.

The teams no longer have home-court advantage. Nor will they have fans in the stands. But they were assigned to one of three deluxe hotels based on the current standings in each conference.

The likely championship contenders who will probablyspend much of the three months together will stay at the Gran Destino Tower at Coronado Springs,middle seeds will stay at the Grand Floridian, andplayoff bubble teams will stay at the Yacht Club.

A recent study showed that limitingthe connections in a population helps to slow the transmission of a virus.

Just because NBA players, coaches and staff members are inside the bubble, the precautions and adviceis generally what the CDC suggests for those of us outside their bubble.

According to the NBAs 113-pagehealth and safety protocol document,masks are required in every public situation except practices and games.

Even during games, though, most of the people attending will be required to wear some kind of face covering.

In the two weeks before the players traveled to Orlando, the NBA required they had to be tested for the coronavirus.

As they arrived in a staggered three-day period fromJuly 7 to 9, each playerwas to quarantine in his roomfor more than 24 hours and complete two negative COVID-19 tests.

After the initial tests, players and staff will"undergo regular coronavirus testing as determined by the NBA in consultation with its medical experts and the (National Basketball Players Association)."

The NBA also says players and staff will be monitored daily:

The NBA says there's no opting out on monitoring for players, staff or guests and says anyone who refuses "will be prohibited from engaging in group activities until the monitoring is accomplished and/or may be required to leave the campus permanently."

Disney employees will be routinely cleaning public spaces such aselevators, lobbiesand handrails.

Disney will also staff takeout restaurants with the same employees to eliminate staff turnover. They will all be required to wear masks and gloveswhile staying at least six feet apart.

To reduce any other potential transmission during their free time, the NBA even suggests players throwing away a deck of cards after every use.

Theyre taking the right approach, UNLV assistant professor of health Brian Labus told USA TODAY in June. "Though they will have some challenges when they actually start to implement it, everything looks good on paper.

One of the big X-factors in maintaining the NBA bubble is the Disney staff members. They won't be required to stay inside the bubble but will be helping the players, coaches and other staff on a daily basis.

"I dont think any reasonable person would say that was a real possibility. Youre talking about hundreds, maybe thousands, of workers in these hotels that would never see their family for three months," said Eric Clinton, the president of UNITE HERE Local 362, which oversees the custodians and ride operators at Disney World.

The union and NBA have agreed on multiple safeguards.Said Clinton: "Theyre going to be scheduled and trained in a way not to interact with the players as much as possible."

Housekeeping staff will beassigned to a specific set of floors at each hotel. Clinton added that there will be specific housekeeping staff devoted to NBA personnel at the Grand Floridianand a different set of staff devoted to timeshare customers.

They will also be monitoring and asking the staff to monitor their own health on a daily basis.

So employees do not feel pressured to work with any illnesses, Disney will pay them for sick days. Disney will also pay any employees who have to self-quarantine should they be diagnosed with COVID-19, regardless of where it originated.

Regardless, the NBA said in its health and safety protocols that the league, players union and Disney "will continue to monitor the ongoing coronavirus situation, including as local, state and national public health recommendations evolve, new or different technologies become available (e.g., related to diagnostic testing or contact tracing), and emerging evidence continues to inform best practices for prevention, control, and mitigation strategies."

"We are continuing to work with Disney on the testing of at least a subset of their employees that could potentially be in the same room with our players and anyone else whos tested daily on our campus," NBA Commissioner Adam Silversaid in June. "So we are satisfied that once we work through those additional measures with Disney, we will continue to have a safe setting for us to resume our season."

Read more here:
How the NBA bubble has taken shape in Disney World - USA TODAY

Read More...

The New Subaru Ascent Arrives This Summer – Everything You Want to Know – Torque News

July 11th, 2020 9:46 pm

If you are looking for a three-row SUV, how do you know if the 2021 Subaru Ascent family hauler is a vehicle you should be on your list? Well give you a quick rundown of the Ascent and give you fuel mileage, cargo capacity, new features, safety ratings, and what trim level hits the sweet spot.

Whats new for 2021?

The 2021 Ascent gets new safety upgrades over the current model worth noting. The new model comes with advanced adaptive cruise control with lane-centering and lane keep assist added to the standard EyeSight driver-assist safety technology. Another newly added safety feature is the steering responsive LED headlights that are now standard across all trim levels, and the second- and third-row seat belt reminder is now standard.

What is the best Ascent trim level?

The 2021 Ascent comes in four trim levels for SUV buyers with a growing family. It comes in Base ($32,295), Premium ($34,795), Limited ($39,595), and top-of-the-line Touring ($45,445). Destination & delivery add $1,050 to the price.

If you dont need leather seats, the2021 Ascent Premiumoffers the best value and features standard all-wheel-drive, X-Mode, EyeSight driver-assist safety tech, and unique spill-repellent cloth upholstery. It getsupgrades for familieslike the all-weather package with heated exterior mirrors and heated front seats and windshield wiper de-icer.

Customers can load up the Premium trim with features and still keep the family hauler under $40,000.

Options on the Premium include second-row captain chairs; 20-inch wheels in a dark gray machine finish, and a power rear gate with height memory. You can also opt for keyless access with push-button start, auto-dimming rearview compass mirror, panoramic moonroof, navigation, and a stow-able cargo cover.

How big is the Subaru Ascent inside?

The 2021 Ascent is the biggest model Subaru offers and comes with 19.6cubic feet of cargo room behind the third row. With the second row folded youll have 47.5 cubic feet and with the third row folded flat, Ascent offers 86.5 cu.ft., big enough to carry two mountain bikes inside or plenty of room for sports gear and your four-legged friends.

If you are hauling people, Ascent can carry up to 8 passengers with the second-row bench seat. Ascent features 153.5cubic feet total passenger volume and offers 38.6 inches of second-row legroom.

Does the Ascent have enough power?

Ascent is powered by a new 2.4-liter direct-injection turbocharged Boxer engine producing 260 horsepower and 277 lb.-ft. of torque. For those who are wondering what torque is in simple terms, its what gets a vehicle moving from a stop and helps in pulling the vehicle up a hill, or when towing. Ascent has a maximum tow rating of 5,000 lbs, and has enough power to tow a small trailer or camper.

What is the fuel mileage of the 2021 Subaru Ascent?

The EPAestimatedfuel economyis 21/27 mpg city/highway and 23 combined mpg for the Premium trim. Ascent Limited and Touring come in at 20/26 city/highway and 22 combined mpg because they are slightly heavier.

What connectivity and convenience features does Ascent offer?

Standard features include tri-zone front and rear automatic climate control, a rear vision camera, a multi-function display, a host of input/charging USB ports, and an amazing 18 cup holders. The Ascent also comes standard with a 6.5-inch multimedia system with smartphone integration capabilities like Apple CarPlay, Android Auto, and Bluetooth connectivity.

How safe is the Ascent?

All Ascent trims come standard with Subarus Symmetrical all-wheel-drive, X-Mode for severe driving conditions, and EyeSight driver-assist technology. The Ascent will be rated the highest Top Safety Pick Plus score from the Insurance Institute for Highway Safety (IIHS) because of the new standard steering responsive LED headlights.

The 2021 Subaru Ascent 3-Row SUV family hauler is built at the U.S. past in Lafayette, Indiana, and begins arriving in Subaru retailers this summer. If you are wondering what the differences between Ascent and the Outback are, check out our complete comparison below.

You Might Also Like: New Subaru Outback Vs. Ascent 3-Row, Which Is The Best Fit For Your Family?

Denis Flierl has invested over 30 years in the automotive industry in a consulting role working with every major car brand. He is an accredited member of the Rocky Mountain Automotive Press and the founder of Subaru Report where he covers all of the Japanese automaker's models. More stories can be found on the Torque NewsSubaru page. Follow Denis on Facebook, Twitter, and Instagram.

Subaru Report - Weve got you covered! Check back tomorrow for more unique, informative SUBARU news, reviews, and previews you can trust.

Leave your comments below, share the article with friends and tweet it out to your followers!

Photo credit: Subaru

Follow this link:
The New Subaru Ascent Arrives This Summer - Everything You Want to Know - Torque News

Read More...

Is it safe to send kids to school? Visit gyms? Attend a protest? N.C. experts weigh in. – Greensboro News & Record

July 11th, 2020 9:45 pm

RALEIGH As North Carolina prepared in late May to enter Phase Two of Gov. Roy Coopers plan to reopen the state in the midst of the coronavirus pandemic, we talked to doctors from UNC and Duke about which Phase Two activities they considered safe or risky.

For this follow-up two months later, we asked our experts how they felt about sending kids (or young adults) to school in the fall; about going to bars, gyms and bowling alleys; and about attending protests.

The first thing we learned from checking back with our experts is that their feelings about the activities we discussed in our first story havent changed much. If anything, most of our doctors held stricter opinions now.

On Saturday, North Carolina had nearly 1,100 people in hospitals with COVID-19 issues, marking the fifth consecutive day the state broke a record for hospitalizations, according to data from the N.C. Department of Health and Human Services. There were 1,093 hospitalizations on Saturday, and the number of positive confirmed cases of coronavirus hit an all-time, one-day high of 2,462 since the virus reached the state in early March.

Compared to May, the risk of being infected with this coronavirus has only increased, said Dr. David Alain Wohl, a professor at the Institute of Global Health and Infectious Diseases at UNC-Chapel Hill.

There are more people infected currently out and about, and many are not mask-wearing or physically distancing either, for reasons that are not evidence-based or because they are being neglectful.

Dr. Amir Barzin, professor and director of UNC Family Medicine Center, has also become more cautious since May.

A lot of what we talked about before still is very applicable to right now, Barzin said. If anything, Im understanding as a physician that this is a longer and longer course, and so my ethical responsibility as a doctor is to try to keep myself healthy and safe longer and longer. So if anything, maybe Ive become a bit more conservative.

In addition to Wohl and Barzin, we followed up with Dr. Tony Moody, associate professor in the Department of Pediatrics at Duke University School of Medicine and member of the Duke Human Vaccine Institute; and Dr. Sallie Permar, a professor of pediatric infectious disease, immunology and molecular genetics at the Duke School of Medicine. In our first round, we also spoke to Regina Petteway, director of Wake County Human Services. Petteway retired on July 1, so for our follow-up, we talked to Chris Kippes, Wake County Public Health division director.

There has been much discussion about reopening bars and gyms, so we asked our experts if those are places they would feel comfortable visiting.

For our experts, its a resounding no particularly in regard to bars.

Wohl told us no way when we asked about bars, and absolutely not when we asked about gyms. As for exercise, I exercise out of doors with others who I stay a generous distance from, Wohl said.

Moody was also a no on bars and gyms.

While I really like the socialization, the bar setting is exactly the kind of place where transmission may be easiest, Moody said. People may have lowered inhibitions, and they are usually in tight quarters, often talking directly into each others faces or ears, especially if conversation and music is loud.

Moody said that like bars, the activities in gyms are exactly those most likely to speed transmission.

People are breathing heavily and may be much less likely to wear a mask, both of which would facilitate virus spread into the air, Moody said.

Also, people may be touching their face more frequently and then depositing infectious particles on surfaces, and it is challenging to have people be scrupulous about cleaning surfaces after every use. Classes (spin, yoga, aerobics, etc.) where you have many people in a tight space are perfect for transmission.

Moody says for now he is working out at home and getting lots of outdoor exercise by biking and walking, making sure he can distance and avoid people.

Even then, he added, Ive taken to carrying a mask so that if I have to approach someone, I can cover up.

Barzin told us that he would definitely not visit a bar right now.

That is one of the absolute hard nos for me, he said, citing an atmosphere favorable to the potential spread of contagion.

Barzin said he understands bar owners desire to reopen, but worries about the long-term repercussions of opening too soon and then having an outbreak associated with a business.

But he said there is, in theory, a right way and a wrong way to reopen.

If you have the opportunity to be outdoors, if you put tables outdoors, that would make it more attractive, I think, Barzin said. It makes it more safe for the patrons. But right now, Im trying to limit exposure in confined areas for prolonged periods of time.

His feelings about gyms are similar.

I think, again, this is one of those situations where you get a lot of people confined, he said. Especially in a gym, people are exerting themselves, they are breathing harder ... that is not an area where Id spend a lot of time.

Permar is in agreement about bars and gyms.

The point of going to a bar, congregating and talking in a group of adults, is a high-risk setting for transmission, she said. Moreover, drinking and universal masking dont mix well. But I would like to be able to order takeout cocktails!

At gyms, the heavy breathing during a workout can be a high-risk setting for transmission, Permar said.

And masking could be seen as a challenge and may be less effective in this setting. Outdoor, spaced group workouts seem like a way for group physical activity to continue.

Kippes said he would not visit a bar at this time. He said he would visit a gym only if the gym was able to assure social distancing, require use of face masks/coverings and have procedures in place to keep equipment clean between individual usage.

The reason we asked this question which on the surface may seem a little random is because of the recent lawsuit in which owners of bowling alleys are demanding they be allowed to reopen. This week, Wake County Superior Court Judge James Gale said Gov. Roy Cooper didnt give good enough evidence why bowling alleys should remain closed.

Our health experts disagree.

Moody said he would probably not go bowling for some of the same reasons he wouldnt go to a bar or gym.

Bowling alleys are generally less crowded and the exertion level is lower, but the enclosed space is still an issue, he said.

Permar said she will avoid this type of indoor activity because it promotes a congregation of adults. (She is very hopeful that drive-in movies will make a comeback, though.)

Barzin also dislikes the idea of a lot of people in one area at the same time.

Bowling is not something we do on a regular basis and not something we would start doing at this time, he said.

Kippes says if the bowling alley was able to assure social distancing and require the use of face coverings, he would consider it.

Wohl was straight and to the point: No offense to bowling fans, but this seems like a really low priority during an ongoing pandemic.

Our experts were a little more mixed in their comfort level attending protests, but primarily agreed that it all depends on the circumstances.

Wohl warned against any mass gatherings, including protests, sporting events or political rallies, where masks are eschewed and people are packed closely together. These types of situations smack of a denial that there is a deadly contagious pathogen circulating in our country, he said.

And when you take those activities indoors, even worse, he said.

But if mask rules and distancing protocols are followed, and it takes place outdoors, Wohl is more comfortable with protests.

Demonstrations organized to promote distancing and face masks and are held in the open air, are less risky, he said. And given the importance of such protests at this moment, (they) are acceptable to me.

Kippes said he would attend an outdoor protest or rally if social distancing was maintained and all who attended wore face masks or coverings.

Permar said she is not only comfortable with attending outdoor protests, she has done it.

I would and have (attend a protest), while wearing a mask and distancing, she said. I support the important fight against systemic racism which has been amplified by these protests over the last few weeks.

Barzin said he supports protests, and feels that the ones where people are spaced and wearing face coverings are a little bit safer in terms of something I would consider doing.

If it was a large mass protest where they werent requiring those things, even though I would feel like the social issues are the correct ones to participate in, I dont know if I would be out there participating in that just based off the fact that my job requires me to be healthy. I want to provide good care for people, I dont want to put any extra risk on myself or my family or my patients.

Moody was conflicted about protests, but echoed Barzins concerns about putting his patients at risk.

Being outdoors is helpful, the crowds are not, he said. I am very supportive of our right as Americans to protest and view the choice to do so, even at a time of pandemic, as intensely personal.

Moody said he has considered attending protests in Raleigh, but in the end opted not to because he feels an obligation to his patients to be well when he sees them.

However, I also have an obligation to my patients to advocate for them, and I have a desire to participate as many of my colleagues and friends have, he said. We all know that 2020 has been a challenging year, and while I have not yet gone to a public protest, I have not ruled it out.

The question of whether or not to send children of any age back to school right now was especially hard for most of our experts. This week, Cooper is expected to announce the states plan for reopening schools, but many parents are conflicted.

There is a terrible tension between the concerns regarding infection at school and the emotional and educational well-being of children and their families, said Wohl, who noted that the American Academy of Pediatrics recommended that students be physically present in school provided transmission mitigating strategies are also in place.

They point out the toll being out of school is taking on children and adolescents, as well as their parents and caregivers, he said. I do think a balance can be arrived at.

When it comes to college students returning to campus, Wohl says that is more challenging when the student resides on campus, rather than at home. This requires a lot of discussion for all those impacted by campus reopening, and a close eye on regional trends related to the pandemic.

Permar, our expert in pediatric infectious disease and immunology, has school-age children and says she will send them back to school.

I support in-person school for all of the benefits that children receive there, including teacher and peer interactions, physical activity and stable meals, that I believe outweighs the risks for children, she said. The limited disease from SARS-CoV-2 infection in children has been consistent. Moreover, there is growing data that children are less likely to transmit to adults versus the other way around, and masking would further reduce transmission.

Permar says that masking teachers and staff and eliminating unmasked interactions with co-workers (for example, no eating together) should provide them protection. This has proven effective in protecting health care workers, she said.

But she stresses that resources must be committed to schools to make sure they have personal protective equipment for staff, adequate cleaning supplies and the ability to physically distance everyone.

We should prioritize opening schools over other parts of society, such as restaurants and bars, and promote the development of harm-reduction metrics to monitor virus transmission and child well-being that are specific to school settings instead of applying measures of adult case numbers only to determine if the benefits continue to outweigh the risks of keeping schools open, Permar said.

Kippes agrees, saying he would send his children back to school or college as long as they have plans that follow recommended guidelines including procedures for social distancing.

Barzin, who has a toddler, recognizes the need for school kids to have social interaction, but isnt sure whats best right now.

Its a really tough decision as a family, he said. Its hard because you really want to promote the educational component and the social interaction, but if youre 6 years old and youre doing that in a separated space, how much benefit is actually there for the child versus the instruction that theyre getting? Its really tough to know.

Moody is perhaps most cautious.

This is challenging, he said. While most data suggests the young are at less risk, its not zero risk. And large gatherings like school are the perfect way to transmit an illness like COVID-19.

That being said, there are very good reasons to send children to school and college, including their education and the social interaction they get.

Moody also recognizes that many parents depend on school so that they can go to work, so there are economic impacts, too.

I dont think this is something that has a single right answer, but I think some degree of caution is needed, he said.

Even with what Moody considers reasonable college plans, which have students on campus without breaks and finishing before Thanksgiving, its hard to prevent the students from interacting with the outside world. And once the virus gets into the student population, it may be hard to control, he added.

As of right now, Im adopting a wait-and-see attitude, and I think we are probably in for some combination of home schooling, smaller classes, and altered schedules for a while to come.

Read more here:
Is it safe to send kids to school? Visit gyms? Attend a protest? N.C. experts weigh in. - Greensboro News & Record

Read More...

HIV patient ‘first in remission’ without transplant – Japan Today

July 11th, 2020 8:50 pm

A HIV-positive man in remission may be the first patient effectively cured of the illness without needing a bone marrow transplant, researchers said Tuesday in a potential breakthrough.

HIV affects tens of millions of people globally and while the disease is no longer the automatic death sentence it once was, patients need to take medication for life.

In recent years two men -- known as the "Berlin" and "London" patients -- appear to have been cured of the disease after undergoing high-risk stem cell bone marrow transplants to treat cancer.

Now an international team of researchers believe they may have a third patient who no longer shows sign of infection after undergoing a different medicine regimen.

The patient, a 34-year-old Brazilian who has not been named, was diagnosed with HIV in 2012.

As part of the study, he was given several potent antiviral drugs, including maraviroc and dolutegravir, to see if they could help him rid the virus from his body.

He has now gone more than 57 weeks with no HIV treatment and he continues to test negative for HIV antibodies.

Ricardo Diaz, an infectious diseases expert at the University of Sao Paulo, said the patient could be considered to be free of the disease.

"The significance for me is that we had a patient that was on treatment and he is now controlling the virus without treatment," he told AFP.

"We're not able to detect the virus and he's losing the specific response to the virus -- if you don't have antibodies then you don't have antigens."

Diaz's findings were released as part of the first-ever all-virtual International AIDS Conference, held online this year due to the coronavirus pandemic.

The United Nations said Monday that 1.7 million people contracted HIV last year and there are now more than 40 million people living with it.

Diaz said his team's treatment method, which needs further research, was a more ethical avenue for gravely ill HIV sufferers than the bone-marrow transplant route.

"They come with a high mortality rate, there have been a series of patients who have either died from the procedures or it didn't work," he said.

Sharon Lewin, co-Chair of the International AIDS Society Initiative Towards an HIV Cure and director of the Doherty Institute for Infection and Immunity in Melbourne, said Diaz's findings were "very interesting".

She struck a note of caution however, due to the study's limitations.

She noted that the Brazil patients' antibody test had gotten weaker over time -- suggesting a diminishing immune response.

"This is very unusual to see in someone off antivirals," she said. "The Berlin and London Patients may be the only exceptions. This very provocative data needs more in-depth analysis."

See the original post:
HIV patient 'first in remission' without transplant - Japan Today

Read More...

Circulating Tumor Cells (CTC) Market Business Overview, Revenue, Price and Gross Margin, Product Specifications, Forecast 2032 Bulletin Line -…

July 11th, 2020 8:50 pm

A new intelligence report Circulating Tumor Cells (CTC) Market Was recently added to Circulating Tumor Cells (CTC) Market Research collection of top-line market study reports. International Circulating Tumor Cells (CTC) Market report is a meticulous all-inclusive analysis of this market that provides access to direct firsthand insights on the growth trail of market at near term and long term. On the grounds of factual advice sourced from authentic industry pros and extensive primary business study, the report offers insights about the historical growth pattern of Circulating Tumor Cells (CTC) Market and present market situation. It then provides brief and long-term market growth projections.

Projections are only based on the comprehensive analysis of key Market dynamics that are expected to influence Circulating Tumor Cells (CTC) Market performance and also their seriousness of impacting market growth within the span of assessment interval.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2638984&source=atm

In addition to evaluation of dynamics, the report supplies In-depth examination of key business trends that are anticipated to behave more prominently in global Circulating Tumor Cells (CTC) Market. The study also provides valued information concerning the present and upcoming growth opportunities in Circulating Tumor Cells (CTC) Market the important players and new market entrants can capitalize on.

Competitive Businesses And manufacturers in global market

The key players covered in this studyAdnaGenApocellBiocepCanopus BioscienceCreatv MicrotechIkonisysIV DiagnosticsMiltenyi BiotechNanostring TechnologiesRarecells DiagnosticsVitatex

Market segment by Type, the product can be split intoEx-Vivo Positive SelectionIn-Vivo Positive SelectionNegative SelectionMicrochips & Single Spiral Micro ChannelMarket segment by Application, split intoTumorigenesis ResearchEmt Biomarkers DevelopmentCancer Stem Cell ResearchOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Circulating Tumor Cells (CTC) status, future forecast, growth opportunity, key market and key players.To present the Circulating Tumor Cells (CTC) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cells (CTC) are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2638984&source=atm

Opportunity assessment offered in this Circulating Tumor Cells (CTC) Market report Is important in terms of understanding the lucrative regions of investment, which prove to be the actionable insights for major market players, providers, distributors, and other stakeholders in Circulating Tumor Cells (CTC) Market.

In-depth global Circulating Tumor Cells (CTC) Market taxonomy presented in this Report offers detailed insights about each of the market segments and their sub-segments, which are categorized based on t par various parameters. An exhaustive regional evaluation of global Circulating Tumor Cells (CTC) Market divides global market landscape into essential geographies.

Regional prognosis and country-wise analysis of Circulating Tumor Cells (CTC) Market Allows for the analysis of multi-faceted operation of marketplace in all of the crucial markets. This information intends to provide a broader scope of report to readers and identify the most relevant profitable areas in global market place.

Taxonomy and geographic analysis of the international Circulating Tumor Cells (CTC) Market enables readers to see profits in present chances and catch upcoming growth chances even until they approach the market location. The analysis given in report is only meant to unroll the economic, societal, regulatory and political situations of this market specific to each area and country, which could help potential market entrants in Circulating Tumor Cells (CTC) Market landscape to comprehend the nitty-gritty of target market areas and invent their plans accordingly.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2638984&licType=S&source=atm

Circulating Tumor Cells (CTC) Market Table of Contents

Originally posted here:
Circulating Tumor Cells (CTC) Market Business Overview, Revenue, Price and Gross Margin, Product Specifications, Forecast 2032 Bulletin Line -...

Read More...

Global Circulating Tumor Cells Market Analysis and Forecast 2027- including drivers, constraints, intimidation, challenges, opportunities, and…

July 11th, 2020 8:50 pm

Global Circulating Tumor Cells Market presents insights into the present and upcoming industry trends, enabling the readers to identify the products and services, hence driving the enlargement and effectiveness. The research report provides a comprehensive breakdown of all the major factors impacting the market on a global and regional scale, including drivers, constraints, intimidation, challenges, opportunities, and industry-specific trends. Further, the report cites global certainties and endorsements along with downstream and upstream analysis of leading players.

Get more information on Global Circulating Tumor Cells Market Research Report by requesting FREE Sample Copy @ https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-circulating-tumor-cells-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/146935#request_sample

Major Players:

BioceptAdnagenNanostring TechnologiesApoCellCanopus BioscienceMiltenyi BiotechVitatexIkonisysRarecells DiagnosticsCreatv MicrotechIV Diagnostics

Global Circulating Tumor Cells Market research reports enlargement rates and the market value based on market dynamics, growth factors. Complete knowledge is based on the newest innovation in business, opportunities, and trends. In addition to SWOT examination by key suppliers, the report contains an all-inclusive market analysis and major players landscape.

The regional segmentation covers:

Segmentation by Type:

Ex-Vivo Positive SelectionIn-Vivo Positive SelectionNegative SelectionMicrochips & Single Spiral Micro Channel

Segmentation by Application:

Tumorigenesis ResearchEMT Biomarkers DevelopmentCancer Stem Cell ResearchOthers

Do Inquiry Before Purchasing Report Here and Ask For Discount @: https://www.globalmarketers.biz/discount_inquiry/discount/146935

Report Objectives

Enquire Before Buying : https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-circulating-tumor-cells-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/146935#inquiry_before_buying

Table of Content:

The Global Circulating Tumor Cells Market

Chapter 1: Circulating Tumor Cells Market Overview, Drivers, Restraints and Opportunities

Chapter 2: Circulating Tumor Cells Market Competition by Manufacturers

Chapter 3: Circulating Tumor Cells Production by Regions

Chapter 4: Production, By Types, Market share by Types

Chapter 5: Consumption, By Applications

Chapter 6: Comprehensive profiling and analysis of Manufacturers

Chapter 7: Manufacturing cost analysis

Chapter 8: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 9: Marketing Strategy Analysis, Distributors/Traders

Chapter 10: Circulating Tumor Cells Market Effect Factors Analysis

Chapter 11: Circulating Tumor Cells Market Forecast

Chapter 12: Conclusion of Circulating Tumor Cells Market

The Report has Tables and Figures Browse The Report Description and TOC @ https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-circulating-tumor-cells-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/146935#table_of_contents

Excerpt from:
Global Circulating Tumor Cells Market Analysis and Forecast 2027- including drivers, constraints, intimidation, challenges, opportunities, and...

Read More...

Be careful of these water-borne diseases during monsoons – The New Indian Express

July 11th, 2020 8:49 pm

Monsoons are a relief after the scorching summer, however, they can bring in a lot of menaces if not managed well. As is with every seasonal change, our bodies try to adjust to the new temperature, and hence, knowing how to prepare oneself is necessary. Speaking about monsoons, especially parts of the country that receive heavy rainfall, a necessary focus becomes immunity, as the transition from summer to monsoon can make it particularly vulnerable. It also increases the chance of getting affected by water-borne diseases such as typhoid, diarrhoea, dysentery, Hepatitis A and E, jaundice, food poisoning, malaria, dengue, certain fungal infections and more.

In light of this, one thing needs to be kept in mind at all times, ie. gut equals immunity. This is the cornerstone of your defence system. Its said that 80 percent of your immunity depends on your gut health, the strength of which depends on an overall lifestyle, and not just a single food item or supplement.Here are some things one must take care of to boost their gut health and bolster immunity:

Avoid consuming raw, green leafy vegetables like spinach, lettuce, cabbage, Brussel sprouts, and others during the monsoon, as they carry a high risk of contamination. Monsoon is also the breeding season for many insects and worms, and they tend to lay eggs on the leaves of plants, so avoid consuming raw leafy greens at any cost. Also, apart from the risk of ingesting pathogens, raw vegetables can upset the digestive system, especially for those who are susceptible to stomach troubles.

*Thoroughly washing of fruits and vegetables is a must in every season, but specially in monsoons, because you never know what we might accidentally consume along with it. You can buy a chemical-free, safe vegetable and fruit-washing solution, or make one on your own.

*Consume seasonal foods during monsoon. This is true of all year round but monsoon is a crucial period. Consume a diet thats local as the fruits and vegetables have certain properties that offer benefits for that particular season. For instance, mangoes available in summer help boost immunity for the upcoming monsoons.

*Make use of common kitchen spices to boost immunity such as turmeric, cumin, ginger, garlic, cloves, basil leaves, and black pepper. You can brew them into tea, make a concoction or a water infusion, or simply add these to your daily cooking.

*Feed your gut good bacteria (probiotics) as well as prebiotics, to maintain a healthy gut microbiome. Prebiotics are necessary too, although, they are often undercooked. Prebiotics serve as food for the probiotics. Good examples of these are garlic, apple, asparagus, apple cider vinegar,and raw banana.

*In case you contract a stomach infection, it may be necessary to include a good quality probiotic supplement that your healthcare expert can recommend.

The author is a Mumbai-based holistic lifestyle coachIntegrative Medicine

Originally posted here:
Be careful of these water-borne diseases during monsoons - The New Indian Express

Read More...

Peer-reviewed JNU study among 2 that link BCG & Covid again, but some experts not convinced – ThePrint

July 11th, 2020 8:49 pm

Text Size:A- A+

Bengaluru: Two studies released this week, one led by Indian researchers from JNU, brought back a theory that first emerged in the early days of the pandemic that BCG vaccination may be linked to reduced Covid-19 transmission and mortality.

One of them, published in the journal Cell Death and Disease on 8 July, was carried out by an international team of researchers. It was led by researchers from the JNU School of Computer and System Sciences, in collaboration with colleagues from the universitys Special Centre for Molecular Medicine and School of Computational and Integrative Sciences, besides those from Italy, China and the US.

The second study, published in PNAS on 9 July, was carried out by American researchers.

The first study involved an assessment of a possible correlation between Covid-19 incidence and mortality with the BCG vaccine, which is primarily targeted at tuberculosis. It also sought to examine the preventive use of chloroquine, an antimalarial drug that has been touted as a potential coronavirus prophylactic and treatment.

While it found a potential correlation between a nations BCG policy and lowered disease incidence/mortality, it failed to find a statistically significant correlation with chloroquine.

The American study also found a potential correlation between BCG vaccination rates and Covid mortality, but the authors suggested further research into the subject.

Both journals are peer-reviewed, but PNAS allows authors to pick reviewers. The studies were both observational assessments based on existing data and not based on clinical trials. The authors themselves acknowledge certain limitations and experts have called for more research before a conclusive link can be proved.

We are deeply grateful to our readers & viewers for their time, trust and subscriptions.

Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrints future.

SUBSCRIBE NOW

Also Read: Can BCG vaccine protect against Covid-19? Heres why the excitement needs to be tempered

The BCG vaccine has been in use since 1921, but works only for an average of 60 per cent of the population. Its use has reduced drastically after decades of vaccination drives the world over, including in the Indian subcontinent.

Today, it is proving inefficient against lung TB, the most common form of the disease in India, but there are studies underway to find a replacement.

But there is some evidence that BCG offers protection to some unrelated viruses like influenza.

The Cell authors classified countries into three groups on the basis of their BCG policy: Countries that never adopted universal BCG vaccination, ones that did but subsequently discontinued it, and ones that currently exercise it.

The authors reportedly found that the number of cases across different age groups was always higher for countries without a BCG policy. For adults aged over 45, vaccinated groups had significantly lower case rates. Vaccination rates did not seem to matter in children under 15 since disease incidence in this group was found to be low.

The PNAS study, too, noted that countries with no vaccination policy had a higher rate of deaths than those that did. Both studies claim that the case load was marginally lower even in countries with interrupted or irregular BCG drives.

The Cell team further speculates that the type of BCG vaccine strain used also plays a role, citing high prevalence despite vaccination in Brazil and Russia.

Many countries, including Germany, the Netherlands, Australia, and the US, have initiated trials of BCG vaccines aimed at controlling Covid-19. Immunologist Gobardhan Das, who participated in the Cell study, claims to be working on developing a revamped BCG vaccine for Covid-19.

Also Read: We need to take a break from real-time updates on the Covid vaccine trials. BCG is a far cry

Many observational studies have suggested a link between BCG and Covid-19, but experts in immunology and BCG have called for more research.

It is true that India has had several decades of safe experience with BCG, which has a proven safety record, is inexpensive, and easily available, said Dr S.P. Kalantri, an epidemiologist and medical superintendent at Kasturba Hospital in Wardha, Maharashtra. But using only observational ecological studies to find a pattern with BCG is problematic.

Ecological studies are observational assessments where existing data is analysed, retrospectively, based on geography, and conclusions drawn from them usually form the basis for further studies.

Intuitively, it seems natural that there is a cause and effect relationship, but what holds true for a country does not hold true for communities or individuals, Kalantri said. In epidemiology, he added, this is called an ecological fallacy.

Kalantri said there are other factors that could contribute to Covid-19 data being the way it is, the most important of which is the average age of the population. The average age of most BCG countries, he added, is lower than that of non-BCG nations.

We know that incidence and mortality is age-specific. As age advances, prevalence and mortality also goes up. In the face of such factors, we shouldnt fall into the trap of concluding that the disease pattern is because of BCGs effects, he added. We need proper randomised controlled trials to show statistical significance, he said.

Said Madhukar Pai, epidemiologist at McGill University, Canada, Several countries now have rapidly escalating Covid-19 outbreaks, including Brazil, India, Russia, Mexico, Peru, Chile. And they all routinely give BCG at birth. So, it is dangerous to make conclusions in such a dynamic situation. We simply cannot act on these ecologic correlations and must wait for randomised trials on BCG and Covid-19.

The study authors also noted their own limitations.

The Cell study only included data from middle- and high-income countries.

The PNAS study stated that the data is difficult to review because of broad differences between countries in socioeconomic status, demographic structure, rural vs urban settings, time of arrival of the pandemic, number of tests and criteria, etc.

Also Read: Why the fight over a coronavirus vaccine will be intense, irrational and even nasty

Subscribe to our channels on YouTube & Telegram

News media is in a crisis & only you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the medias economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the countrys most robust editing and fact-checking team, finest news photographers and video professionals. We are building Indias most ambitious and energetic news platform. And we arent even three yet.

At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrints future. It will take just a few seconds of your time.

Support Our Journalism

Read more:
Peer-reviewed JNU study among 2 that link BCG & Covid again, but some experts not convinced - ThePrint

Read More...

Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,…

July 11th, 2020 8:48 pm

The global stem cells market is driven by various factors which include increasing prevalence and incidence rate of cancer and cancer-related diseases. Rising research and development programs, increasing awareness related to regenerative treatment, increasing the use of biomarkers and growth in biopsy market are also driving the market. The high prevalence of cancer in children is also a key driving factor for stem cell study. The number of stem cell banks has increased exponentially.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

The number of hospitals and research centers in developed countries is capable of storing stem cells. Even in countries such as China and India, the growing awareness amongst the professionals and masses is the key driver for the market. India, China, and other emerging nations are also offering stem cell therapies and services and lower cost which is leading to the emergence of medical tourism in the stem cells market.

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

The market is segmented on the basis of product type, applications, and technology. The product types consist of adult stem cells, human embryonic stem cells market, induced pluripotent stem cells market, and very small embryonic-like cells market. Applications include regenerative medicines market which is further segmented as cancer regenerative medicines market, orthopedics regenerative medicines market, hematological regenerative medicines market, neurological regenerative medicines market, cardiovascular regenerative medicines market, regenerative medicines market, injuries regenerative medicines market and others regenerative medicines market.

Drug discovery is also a major application. Stem cells market by technology includes bone marrow harvest, apheresis, umbilical blood cord, therapeutic cloning, in vitro fertilization, isolation, cell culture, cryopreservation, and expansion and subculture.

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

Geographically, the market is a segment as North America, Europe, Asia Pacific and the rest of the world. North America has the highest market share followed by Europe and the Asia Pacific. The Asia Pacific is expected to report the highest growth rate for the forecasted period. Key companies in the market include STEMCELL technologies, Millipore, Corning, BioTime Inc, Advanced Cell technology Inc, Cellular engineering technologies and other major companies.

How does the report examine the growth drivers and restraints of the Stem Cells Market?

Request To Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10233576

Company profiles

1. STEMCELL technologies2. Millipore3. Corning4. BioTime Inc5. Advanced Cell Technology Inc6. Cellular engineering technologies7. Cellartis AB8. Angel Biotechnology9. Bioheart Inc10. Cellgene corporation11. Brainstorm cell therapeutics12. Osiris therapeutics13. BD biosciences14. Lonza15. ATCC16. Allcells17. Miltenyi biotec GmBH18. QIAGEN19. Novocell20. Stemgent21. Sigma Aldrich22. Invitrogen23. Nunc24. Peprotec25. R&D systems26. Cellular dynamics international27. ChanTest corporation28. Wiicell research institute29. Hybrid Organ GmBH30. BIOE31. Aastrom Biosciences32. California Stem Cells33. International Stem Cell Corporation34. NeoStem35. NeuralStem36. Medistem37. Apceth38. Cardio3 BioSciences39. TiGenix

This Research Report covers

1. Historical data2. Revenue forecasts, growth rates and CAGR up to 20283. Industry Analysis4. Competitive Analysis5. Key geographic growth data

Request for Complete Report:https://www.kennethresearch.com/sample-request-10233576

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides a significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products demand, growth, and opportunities for new and existing players.

Updated Research Report Available @Kenneth Research with impact analysis of COVID-19

In-Office Dental Bleaching Kits MarketInnohep MarketInlet and Exhaust Manifold MarketInjectable Anticoagulants MarketInhalation Generic Drug MarketInfusion System Market

View post:
Impact Analysis of COVID-19 on Stem Cells Market Study 2018-2028 Segmented On The Basis of Product Type, Geographical Analysis, Future Forecast,...

Read More...

Rapid Industrialization in Developing Countries to Aid the Growth of the Cell Expansion Market 2017 2025 – Cole of Duty

July 11th, 2020 8:45 pm

Global Cell Expansion market Research presents a Comprehensive scenario Which can be segmented according to producers, product type, applications, and areas. This segmentation will provide deep-dive analysis of the Cell Expansion business for identifying the growth opportunities, development tendencies and factors limiting the development of the marketplace. This report features forecast market information based on previous and present Cell Expansion industry scenarios and growth facets. Each of the Essential regions coated in Cell Expansion report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Cell Expansion market share and market prognosis of every region from 2020-2027 are presented within this report. A deep study of Cell Expansion marketplace dynamics will help the market aspirants in identifying the business opportunities that will lead to accumulation of earnings. This segment can efficiently determine the Cell Expansion hazard and key market driving forces.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/15757

The Cell Expansion report is segmented to provide a clear and Precise view of this international Cell Expansion market statistics and market quotes. Cell Expansion report Information represented in the form of graphs, charts, and statistics will show the Cell Expansion growth rate, volume, goal customer analysis. This report presents the significant data to all Cell Expansion business aspirants which will facilitate useful business decisions.

Key Players

The major players in cell expansion market include Beckman Coulter, Inc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Terumo BCT, Inc., Corning, Inc., Stemcell Technologies, Inc., GE Healthcare, Merck KGaA (Sigma-Aldrich Co. LLC), Lonza, Miltenyi Biotec among others. Companies have several ongoing research for cell-based therapies and stem cell-based therapies; it has been found that companies are in the development of new products and systems which ensure market growth during the forecast period. Only a few manufacturing companies are involved in the manufacturing of cell expansion instruments.

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/15757

The Cell Expansion report cover following data points:

Part 1: This part enlists the global Cell Expansion marketplace Overview, covering the simple market debut, market analysis by kind, applications, and areas. Cell Expansion industry states and prognosis (2020-2027) is presented in this part. Additionally, Cell Expansion market dynamics saying the chances, market risk, and key driving forces are studied.

Part 2: This part covers Cell Expansion manufacturers profile based On their small business overview, product type, and application. Additionally, the sales volume, Cell Expansion product price, gross margin analysis, and Cell Expansion market share of every player is profiled in this report.

Part 3 and Part 4: This part presents the Cell Expansion competition Based on earnings, earnings, and market share of each producer. Part 4 covers the Cell Expansion market scenario based on regions. Region-wise Cell Expansion sales and growth (2015-2019) is studied in this report.

America and Europes Cell Expansion industry by countries. Under this Cell Expansion revenue, market share of those nations like USA, Canada, and Mexico is provided. Under Europe Cell Expansion report contains, the countries such as Germany, UK, France, Russia, Italy, Russia and their sales and growth is coated.

Part 7, Part 8 and Part 9: These 3 sections covers Cell Expansion The earnings and expansion in these regions are presented in this Cell Expansion industry report.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/15757

Part 10 and Part 11: This component depicts the Cell Expansion marketplace Share, earnings, sales by product type and application. The Cell Expansion sales growth seen during 2012-2020 is covered in this report.

Related to Cell Expansion market (2020-2027) for every region. The sales channels including indirect and direct Cell Expansion advertising, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These components present Cell Expansion market key Research findings and judgment, research methodology, and data sources are covered.

Therefore, Global Cell Expansion report is a complete blend covering all The very important market aspects.

Read more:
Rapid Industrialization in Developing Countries to Aid the Growth of the Cell Expansion Market 2017 2025 - Cole of Duty

Read More...

CHIR 99021 Market: Business Opportunities, Current Trends and Industry Analysis by 2023 – Cole of Duty

July 11th, 2020 8:45 pm

In this report, the global CHIR 99021 market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2019 to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2019 to 2025.

The CHIR 99021 market report firstly introduced the basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the CHIR 99021 market report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2708579&source=atm

Segment by Type, the CHIR 99021 market is segmented intoLow Purity(Below 97%)Purity(Above 97% and Below 99%)High Purity(Above 99%)Others

Segment by Application, the CHIR 99021 market is segmented intoCancer TreatmentNeurological TreatmentEndocrinological TreatmentOthers

Regional and Country-level AnalysisThe CHIR 99021 market is analysed and market size information is provided by regions (countries).The key regions covered in the CHIR 99021 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and CHIR 99021 Market Share AnalysisCHIR 99021 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in CHIR 99021 business, the date to enter into the CHIR 99021 market, CHIR 99021 product introduction, recent developments, etc.The major vendors covered:R&D SystemsAbcamStemgentCayman ChemicalSanta Cruz BiotechnologySTEMCELL TechnologiesAlfa ChemistryAnwardRace ChemicalGlentham Life SciencesAbMole BioscienceAurum Pharmatech LLCTocris Bioscience

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2708579&source=atm

The study objectives of CHIR 99021 Market Report are:

To analyze and research the CHIR 99021 market status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

To present the CHIR 99021 manufacturers, presenting the sales, revenue, market share, and recent development for key players.

To split the breakdown data by regions, type, companies and applications

To analyze the global and key regions CHIR 99021 market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends, drivers, influence factors in global and regions

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the keyword market.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2708579&licType=S&source=atm

More:
CHIR 99021 Market: Business Opportunities, Current Trends and Industry Analysis by 2023 - Cole of Duty

Read More...

Gran who lied blindness to steal 1 million in benefits was ‘craftiest woman ever’ – Mirror Online

July 11th, 2020 7:49 pm

A shameless grandmother who stole more than 1 million in benefits has been called the "craftiest woman ever" by her husband.

Christina Pomfrey, 65, used the first name of his husband's late first wife, and falsely claimed she was blind, disabled and suffering from multiple sclerosis as she carried out the con for 15 years, a court heard last month.

At one point she was banking more than 13,000 a month after fraudulently claiming a number of benefits - and she will not have to pay back a single penny of it.

Pomfrey, from Runcorn, Cheshire, convinced her third husband, John, that she owned a string of newsagents and blew the money on everything from clothes and cosmetic treatments to luxury getaways in the Caribbean.

She laundered almost 89,000 over six years through the bank account of her 34-year-old daughter Aimee Brown, the court heard.

Mr Pomfrey said he had no idea his wife of 15 years was carrying out the scam - or claiming to be blind and confined to a wheelchair - until she was caught.

He told the Daily Mail: "She has destroyed my life and I cannot forgive her. She is the craftiest woman I have ever known."

When he met his wife at a Seventies disco at a Butlin's holiday park in Skegness, Lincolnshire, she claimed she was a millionaire who owned seven newsagents around Liverpool.

She was always well-dressed and had "immaculate hair", she bought him an MG car just months after the met and she paid for their holidays abroad, he said.

But she was hiding the truth - she worked in a newsagent's until she was sacked for stealing cash.

She kept up the pretence until December 2017.

Mr Pomfrey, a water softener engineer, added: "I fell for her because I was at a low ebb after my previous wife of 21 years left me for someone else. Tina told me she would look after me and that I should not worry about anything.

"I now think she picked on me because I was another name, in another county, that she could use for her cons. I feel a fool."

Neighbours were stunned that she was able to get away with the con for so long.

The scam unravelled in 2017 when undercover investigators from the Department for Work and Pensions (DWP) put her under surveillance.

They filmed her walking around Asda unaided, driving a car, reading a newspaper and picking up her grandchildren from school, the Liverpool Echo reported.

Pomfrey confessed, but launched another bogus claim while on bail.

Last month, at Minshull Street Crown Court in Manchester, she was sentenced to three years and eight months for 34 counts including fraud, false accounting and making or supplying articles for use in frauds.

When she was jailed, the Crown Prosecution Service confirmed that Pomfrey was not subject to a confiscation order.

A spokesperson for the CPS said no assets linked to Pomfrey could be traced during the DWP's investigation into her claims.

Meaning she had squandered a staggering 1,010,090.66 over 15 years.

During one fraud, she claimed it took her up to ten minutes to walk three yards because of her MS. She also claimed she had been totally blind since 2007.

Pomfrey claimed that her sister acted as a personal assistant helping her with her care - a claim her sister remained oblivious to.

As such, when her sister tried to make a legitimate claim for tax credits, she was refused because of Pomfreys fraudulent claims.

When she was arrested in 2017, Pomfrey immediately admitted her guilt.

Despite this - while still under investigation - she made further dishonest benefit claims for Universal Credit in which she lied again about her health and circumstances and falsified documents.

Promfrey's daughter, Aimee Brown, was sentenced to 18 months imprisonment suspended for two years for money laundering.

Follow this link:
Gran who lied blindness to steal 1 million in benefits was 'craftiest woman ever' - Mirror Online

Read More...

Puppies and burnout: The impact of the coronavirus on veterinarians – TheChronicleHerald.ca

July 11th, 2020 7:48 pm

Jean-Yin Tan, University of Calgary

At a superficial glance, becoming a veterinarian seems like the realization of an animal lovers childhood dream devoting a career to the care of animals.

What many dont realize is the level of mental health distress associated with the profession in terms of work-life balance, emotional stress and financial health. Research has shown that veterinary professionals are already at high risk of suicide due to occupational stress, depression and burnout.

COVID-19 is having a further impact on vets. Earning a living as a veterinarian is directly tied to the financial success of a business, and the disruption from the pandemic has had a big impact on small businesses, including veterinary practices.

The owner of one successful mixed-animal veterinary practice in Alberta was willing to share with me his practices pandemic experiences and the impact of economic policies during this critical time.

One vital theme emerged from the conversation: any financial strain has been eclipsed by the emotional toll of the pandemic and the need to plan for the unknown.

As stewards of animal and public health, veterinarians have been authorized to provide services during the pandemic. The most visible impact on small animal veterinary services has been the influx of newly acquired puppies to the clinic.

Noting 50-person wait lists for dog adoptions and empty animal shelters, the Alberta veterinarian Ill call him Dr. Brian Jones because he asked that his real name not be used muses that puppies are like Toilet Paper 2.0.

Despite financial uncertainty facing many families, pet adoption and fostering has increased in Calgary as people found themselves with extra time at home and sought to fill a need for companionship.

As puppies grow older in their new homes, hopefully a short-term decrease in demand for vet services due to the pandemic will translate to a permanent increase in demand as veterinary practices gain new canine patients for life.

By contrast, large animal clientele have taken a financial hit from the pandemic, and this has had an impact on large animal veterinary services.

For Jones bovine clients, the closure of processing plants has been devastating, with the backlog of cattle hurting the calf market.

The vet explains that cattle ranchers and others in agriculture are price takers, meaning they input the costs of vaccinations, feeding and medications, with no knowledge of their ultimate price at market and return on investment. The uncertainty posed by the pandemic has placed a great deal of stress on his cattle-ranching clientele.

The different experiences of his practices small and large animal clientele have demonstrated the differences between demand for small animals pets are usually adopted to become longtime family members and large farm animals. The large losses suffered by the agricultural market as a result of the COVID-19 pandemic highlight a more volatile demand for large animal veterinary services.

Veterinarians play an important role as stewards of food safety, public health and animal health.

When veterinary services received essential status at the onset of the pandemic, the industry pledged to limit non-essential procedures so that ventilators, surgical masks and other critical supplies could be conserved for use in human hospitals.

Jones explains: We werent sure how many gloves we would have and how much oxygen we would have, and therefore vets made a conscientious effort to voluntarily reduce the supply of veterinary procedures and services in order to reduce consumption of medical supplies.

But according to the vet, the reduction in the number of staff working each shift as well as long hours has resulted in high emotional wear and tear, to the point that hes worried about worker burnout.

Furthermore, curbside dropoffs of pets to fulfil social distancing requirements have removed the face-to-face interaction between animal owner and veterinarian.

Not only is the added layer of phone calls with each client time-consuming, it also adds to the challenge of using non-verbal cues in conversation in order to have meaningful discussions that result in shared decision-making in health care.

Although government assistance programs are well-intentioned, Jones veterinary practice discovered first-hand how such programs can fail small businesses.

Without access to experts to help them navigate the eligibility requirements of each program and the paperwork to apply, his practice did not ultimately qualify for the Canada Emergency Wage Subsidy, while it may have qualified for the work-sharing program.

Jones acknowledged that the stress and time spent applying for the programs added to the emotional toll on his staff, with only disappointing results when they were unable to take advantage of any of them.

Although veterinarians were granted essential service status and some have been financially stable through the crisis due to consistent consumer demand for vet services, the pandemics emotional toll has been severe.

With veterinary professionals already stressed out emotionally, its more important than ever to evaluate how these essential workers can be supported during the COVID-19 pandemic and beyond.

Jean-Yin Tan, Senior Instructor in Veterinary Medicine, University of Calgary

This article is republished from The Conversation under a Creative Commons license. Read the original article.

RELATED:

See the original post here:
Puppies and burnout: The impact of the coronavirus on veterinarians - TheChronicleHerald.ca

Read More...

Mifepristone Increases Lifespan in Flies and Worms…Can It Improve Longevity in Humans? – MedicalResearch.com

July 11th, 2020 7:46 pm

MedicalResearch.com Interview with:

John Gerard TowerProfessor of biological sciencesUniversity of Southern California

MedicalResearch.com: What is the background for this study?

Response: Mifepristone is a synthetic steroid drug that is used in humans for birth control and as a treatment for Cushings disease, and is currently in clinical trials as an anti-cancer treatment.

We have previously shown that mifepristone dramatically increases the life span of mated female Drosophila flies.

MedicalResearch.com: What are the main findings?

Response: In the present study, we find that mifepristone increases fly life span by altering genes and metabolic pathways that are shared with humans, including interactions with the microbiome.

In addition, we find that mifepristone increases the life span of mated C. elegans worms.

MedicalResearch.com: What should readers take away from your report?

Response: It is striking how conserved the regulation of life span appears to be across species. The metabolism associated with a long, healthy life in humans is similar to the metabolism associated with a long, healthy life in flies, and this is promoted by mifepristone. The finding that mifepristone can increase life span in species as different as fly and worm suggests the possibility that mifepristone might also be able to increase life span in humans.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: It will be important to identify the exact molecular target of mifepristone in the fly, as this remains unknown, and identifying this target may be useful for designing further anti-aging interventions. It may also be of interest to design human clinical trials to test for possible life span effects of mifepristone.

Nothing to disclose.

Citation:

John Tower, Sean P Curran, Daniel E L Promislow, Jie Shen, Mina Abdelmesieh, Shinwoo Lee, Palak Patel, Jimmy Wu, Tianyi Wang, Jonah Vroegop, Ina Wang, Yang Fan, Lu Wang, Chia-An Yen, Devon V Doherty, Gary N Landis.Metabolic Signatures of Life Span Regulated by Mating, Sex Peptide and Mifepristone/RU486 in Female Drosophila melanogaster.The Journals of Gerontology: Series A, 2020; DOI:10.1093/gerona/glaa164

We respect your privacy and will never share your details.

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

1

Excerpt from:
Mifepristone Increases Lifespan in Flies and Worms...Can It Improve Longevity in Humans? - MedicalResearch.com

Read More...

Biotechnology Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By Top Players -…

July 11th, 2020 6:47 pm

Biotechnology Market (2019) Report Provides an in-depth summary of Biotechnology Market Status as well as Product Specification, Technology Development, and Key Manufacturers. The Report Gives Detail Analysis on Market concern Like Biotechnology Market share, CAGR Status, Market demand and up to date Market Trends with key Market segments.

The latest report about the Biotechnology market provides a detailed evaluation of the business vertical in question, alongside a brief overview of the industry segments. An exceptionally workable estimation of the present industry scenario has been delivered in the study, and the Biotechnology market size with regards to the revenue and volume have also been mentioned. In general, the research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2705765&source=atm

Scope of The Biotechnology Market Report:

This research report for Biotechnology Market explores different topics such as product scope, product market by end users or application, product market by region, the market size for the specific product Type, sales and revenue by region forecast the Market size for various segments. The Report provides detailed information regarding the Major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Biotechnology market. The Biotechnology Market Report analyzes opportunities in the overall Biotechnology market for stakeholders by identifying the high-growth segments.

segment by Type, the product can be split intoDNA SequencingNanobiotechnologyTissue engineering and RegenerationFermentationCell Based AssayPCR TechnologyChromatography MarketOthersMarket segment by Application, split intoHealthFood & AgricultureNatural Resources & EnvironmentIndustrial ProcessingBioinformaticsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Biotechnology status, future forecast, growth opportunity, key market and key players.To present the Biotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biotechnology are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2705765&source=atm

A detailed overview of the geographical and competitive sphere of the Biotechnology market:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2705765&licType=S&source=atm

Table of Content of The Report

Chapter 1- Biotechnology Industry Overview:

1.1 Definition of Biotechnology

1.2 Brief Introduction of Major Classifications

1.3 Brief Introduction of Major Applications

1.4 Brief Introduction of Major Regions

Chapter 2- Production Market Analysis:

2.1 Global Production Market Analysis

2.1.1 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

2.1.2 Major Manufacturers Performance and Market Share

2.2 Regional Production Market Analysis

Chapter 3- Sales Market Analysis:

3.1 Global Sales Market Analysis

3.2 Regional Sales Market Analysis

Chapter 4- Consumption Market Analysis:

4.1 Global Consumption Market Analysis

4.2 Regional Consumption Market Analysis

Chapter 5- Production, Sales and Consumption Market Comparison Analysis

Chapter 6- Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7- Major Classification Analysis

Chapter 8- Major Application Analysis

Chapter 9- Industry Chain Analysis:

9.1 Up Stream Industries Analysis

9.2 Manufacturing Analysis

Chapter 10- Global and Regional Market Forecast:

10.1 Production Market Forecast

10.2 Sales Market Forecast

10.3 Consumption Market Forecast

Chapter 11- Major Manufacturers Analysis:

11.1.1 Company Introduction

11.1.2 Product Specification and Major Types Analysis

11.1.3 Production Market Performance

11.1.4 Sales Market Performance

11.1.5 Contact Information

11.2.1 Company Introduction

11.2.2 Product Specification and Major Types Analysis

11.2.3 Production Market Performance

11.2.4 Sales Market Performance

11.2.5 Contact Information

Chapter 12- New Project Investment Feasibility Analysis:

12.1 New Project SWOT Analysis

12.2 New Project Investment Feasibility Analysis

Continued

Excerpt from:
Biotechnology Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By Top Players -...

Read More...

Page 463«..1020..462463464465..470480..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick